SlideShare ist ein Scribd-Unternehmen logo
1 von 26
Accountability – Executive Management of
Clinical Investigation Programs



    Mr. John E. Baker
    General Counsel
    Uniformed Services University of the Health
    Sciences
    jbaker@usuhs.mil

    Ms. Carol Cooper
    Associate General Counsel
    TRICARE Management Activity
    carol.cooper@tma.osd.mil
Clinical Investigation

   •   What are we talking about?
       • Research – Systematic investigation designed to develop or
         contribute to generalizable knowledge – 32 C.F.R.
         219.102(d)
   •   Why?
       • “Cutting Edge” Care, Training, Mission
   •   Who’s accountable?
       • Individual researchers and health care providers, IRBs,
         facility commanders/staffs, the services, DoD
   •   What are we accountable for?
       • Adherence to all applicable laws and statutes, ethical
         decision-making and judgment
Objectives



    •   Identify the regulations regarding the conduct of clinical investigations
        research in medical activities

    •   Demonstrate the function, role, and responsibilities of an Institutional
        Review Board (IRB)

    •   Understand the issues regarding informed consent in clinical
        research

    •   Understand the future challenges in clinical research
Objective 1




     •   Identify the regulations regarding the conduct of clinical
         investigations research in medical activities
Basic Principles




     •   Belmont Report
          • Respect for persons
          • Beneficence
          • Justice

     •   The Technical Stuff Matters Too
          • “t”s and “i”s
Office for Human Research Protections (OHRP)




     •   Public Health Service Act 1974

     •   Common Rule – 45 C.F.R. Part 46
          • 16 Federal Agencies + HHS
          • Ethical Principles
          • Prospective Review by IRBs
References




    •   CFRs:
         • 45 CFR 46.101 (definitions and explanations of IRBs,
           assurances, informed consent)
         • 32 CFR 219.101-124

    •   DoD:
         • DODDIR 3216.2 (Protection of Human Subjects)
References




    •   Army:

        • AR 40-38 (clinical investigation program)

        • AR 70-25 (use of volunteers as research subjects)
References




    •   Navy:

        • SECNAVINST 3900.39C (Protection of Human Subjects)

        • BUMEDINST 6000.12A (Clinical Investigation Program)

        • BUMEDINST 3900.6B (Protection of Human Subjects)
References




    •   Air Force:

        • AFPD 40-4 (Clinical Investigation and Human Use in
          Medical Research)

        • AFI 40-402 (Protection of Human Subjects in Biomedical
          and Behavioral Research)
Objective 2




     •   Demonstrate the function, role, and responsibilities of an
         Institutional Review Board (IRB)
Protocol Approval Process




    •   Assurances

    •   Protocols

    •   Scientific Review

    •   Human Use
Institutional Review Boards (IRB)




    •   Duties: Approve, Disapprove, Modify
         • Monitor, Continuing Review
         • Suspend, Terminate

    •   For each Protocol:
         • Risk/Benefit Analysis
         • Plan to minimize Risks
         • Informed Consent
         • Privacy/Confidentiality
Institutional Review Boards (IRB)




    •   Composition:
         • Minimum 5 Members
         • Both Genders
         • Scientific/Nonscientific
         • Nonaffiliated with Institution
         • Diversity in Experience and Expertise
         • Sensitive to Community
         • Knowledgeable of Applicable Regulations
IRB Issues



    •   Research Subject Selection/Recruitment

    •   Compensation of Subjects
         • 24 U.S.C. § 30

    •   Minimizing Risks

    •   Medical Monitor

    •   Military Unique Environments

    •   Conflicts of Interest
IRB Issues




    •   Overseas

    •   Special Subjects
         • Children (Assent)
         • Prisoners
         • “Emergency” Research
IRB Process



    •   Greater than Minimal Risk

    •   Expedited Review

    •   Exempt Research (32 C.F.R. 219.101)
         • Educational Practices, Tests & Surveys
         • Existing Data
         • Elected Officials
         • Public Benefit Service Programs
         • Consumer Acceptance

    •   Continuing Review
Objective 3




     •   Understand the issues regarding informed consent in clinical
         research
Informed Consent

•   Research Acknowledgement   • Alternatives

•   Purpose of Study           • Compensation

•   Describe Procedures
                               • Medical Care for Injuries
     • Duration
     • Experimental
                               • Voluntary Nature
•   Potential Risks               – Withdrawal


•   Potential Benefits         • POC for Questions
Objective 4




     •   Understand the future challenges in clinical research
Command Issues



    •   Outside Sponsorship

    •   Technology Transfer
         • CRADAs

    •   “Sensitive” Research

    •   Cooperative Research
         • Joint IRBs

    •   Publication
On The Horizon


    •   Recommendations for Reform:

        • Recast IRB Requirements

        • Strengthen Continuing Protections

        • Enact Educational Requirements

        • Insulate IRBs from Conflicts

        • Recognize Workload Pressures

        • Reengineer Federal Oversight Process
Individual Accountability




    •   Researcher Charged With Negligent Homicide (Criminal
        Liability)

    •   IRB Chair Named in Million $$ Lawsuit (Civil Liability)

    •   Commander Relieved (Malfeasance, Nonfeasance,
        Administrative Action)

    •   15-6 Investigation for Research Misconduct Clears Lab
        Personnel
Institutional Liability




     •   U.S. Halts Research on Humans at Duke University

     •   Johns Hopkins: Healthy Volunteer in Asthma Trial Dies After
         Inhaling Drug

     •   DOD Grounds Medical Research Program at
         ________________
The Bottom Line




    •   Leadership

    •   Visibility

    •   Good People

    •   Support
Questions/Answers




    •   Your Team (Research Director, IRB Chair, IRB Administrator,
        Legal Advisor)

    •   Technical Chain (DCS-Research/SG Legal Advisor)

    •   http://www.bioethics.gov

    •   jbaker@usuhs.mil

    •   carol.cooper@tma.osd.mil

Weitere ähnliche Inhalte

Was ist angesagt?

Ethical guidelines for biomedical research in human participants
Ethical guidelines for biomedical research  in human participantsEthical guidelines for biomedical research  in human participants
Ethical guidelines for biomedical research in human participants
gangireddysaisneha
 
Ethical principles for conducting research with human participants
Ethical principles for conducting research with human participantsEthical principles for conducting research with human participants
Ethical principles for conducting research with human participants
Raghad Abutair
 
Ethical committee-role, Principal Investigator
Ethical committee-role, Principal InvestigatorEthical committee-role, Principal Investigator
Ethical committee-role, Principal Investigator
Gayathri Ravi
 

Was ist angesagt? (20)

Ethical guidelines for biomedical research in human participants
Ethical guidelines for biomedical research  in human participantsEthical guidelines for biomedical research  in human participants
Ethical guidelines for biomedical research in human participants
 
Ethics in clinical research
Ethics in clinical researchEthics in clinical research
Ethics in clinical research
 
Lecture 18 research ethics (1)
Lecture 18 research ethics (1)Lecture 18 research ethics (1)
Lecture 18 research ethics (1)
 
Research ethics (Prof Mohamed Ali Albar)
Research ethics (Prof Mohamed Ali Albar)Research ethics (Prof Mohamed Ali Albar)
Research ethics (Prof Mohamed Ali Albar)
 
MEDICAL ETHICS IN RESEARCH PROPOSALS ( Indian contest )
MEDICAL ETHICS INRESEARCH PROPOSALS  ( Indian contest )    MEDICAL ETHICS INRESEARCH PROPOSALS  ( Indian contest )
MEDICAL ETHICS IN RESEARCH PROPOSALS ( Indian contest )
 
institutional review board and independent ethics committee
institutional review board and independent ethics committeeinstitutional review board and independent ethics committee
institutional review board and independent ethics committee
 
Research or not research (jcb 17.11.21)
Research or not research (jcb 17.11.21)Research or not research (jcb 17.11.21)
Research or not research (jcb 17.11.21)
 
Institutional Review Board
Institutional Review BoardInstitutional Review Board
Institutional Review Board
 
ICMR guidelines for IEC - an overview
ICMR  guidelines for IEC -  an overviewICMR  guidelines for IEC -  an overview
ICMR guidelines for IEC - an overview
 
Ethical principles for conducting research with human participants
Ethical principles for conducting research with human participantsEthical principles for conducting research with human participants
Ethical principles for conducting research with human participants
 
Biowaste management
Biowaste managementBiowaste management
Biowaste management
 
Ethical committee-role, Principal Investigator
Ethical committee-role, Principal InvestigatorEthical committee-role, Principal Investigator
Ethical committee-role, Principal Investigator
 
ICMR
ICMRICMR
ICMR
 
Scientific Research And Ethics by Manu Shreshtha
Scientific Research And Ethics by Manu ShreshthaScientific Research And Ethics by Manu Shreshtha
Scientific Research And Ethics by Manu Shreshtha
 
Ethical and legal issues related to human-derived tissues (I)
Ethical and legal issues related to human-derived tissues (I)Ethical and legal issues related to human-derived tissues (I)
Ethical and legal issues related to human-derived tissues (I)
 
Chesapeake IRB: The evolution of ethics in clinical research
Chesapeake IRB: The evolution of ethics in clinical researchChesapeake IRB: The evolution of ethics in clinical research
Chesapeake IRB: The evolution of ethics in clinical research
 
Research misconduct
Research misconductResearch misconduct
Research misconduct
 
Good Clinical Practices
Good Clinical PracticesGood Clinical Practices
Good Clinical Practices
 
Ethical and legal issues related to human-derived tissues (II)
Ethical and legal issues related to human-derived tissues (II)Ethical and legal issues related to human-derived tissues (II)
Ethical and legal issues related to human-derived tissues (II)
 
Ethical Dimensions in the Biomedical Innovations in India: An Analysis
Ethical Dimensions in the Biomedical Innovations in India: An AnalysisEthical Dimensions in the Biomedical Innovations in India: An Analysis
Ethical Dimensions in the Biomedical Innovations in India: An Analysis
 

Andere mochten auch

Session 14 - Incorporating Improvement into Performance Plan
Session 14 - Incorporating Improvement into Performance PlanSession 14 - Incorporating Improvement into Performance Plan
Session 14 - Incorporating Improvement into Performance Plan
MedXellence
 

Andere mochten auch (17)

02 教育目標
02 教育目標02 教育目標
02 教育目標
 
04 学習者評価
04 学習者評価04 学習者評価
04 学習者評価
 
Jsishビジョン
JsishビジョンJsishビジョン
Jsishビジョン
 
身体診察
身体診察身体診察
身体診察
 
Session 14 - Incorporating Improvement into Performance Plan
Session 14 - Incorporating Improvement into Performance PlanSession 14 - Incorporating Improvement into Performance Plan
Session 14 - Incorporating Improvement into Performance Plan
 
03 教育方略・実施
03 教育方略・実施03 教育方略・実施
03 教育方略・実施
 
14 04 needs assessment
14 04 needs assessment14 04 needs assessment
14 04 needs assessment
 
15 04-15 needs assessment
15 04-15 needs assessment15 04-15 needs assessment
15 04-15 needs assessment
 
02 教育目標
02 教育目標02 教育目標
02 教育目標
 
Ipe多職種連携教育
Ipe多職種連携教育Ipe多職種連携教育
Ipe多職種連携教育
 
08 臨床教育の方法論
08 臨床教育の方法論08 臨床教育の方法論
08 臨床教育の方法論
 
15 04-22 strategies
15 04-22 strategies15 04-22 strategies
15 04-22 strategies
 
06 医学教育プログラム評価とPCM
06 医学教育プログラム評価とPCM06 医学教育プログラム評価とPCM
06 医学教育プログラム評価とPCM
 
01 カリキュラム開発
01 カリキュラム開発01 カリキュラム開発
01 カリキュラム開発
 
07 リーダーシップ
07 リーダーシップ07 リーダーシップ
07 リーダーシップ
 
05 学習者評価
05 学習者評価05 学習者評価
05 学習者評価
 
Session 4 American Healthcare - Meyer
Session 4   American Healthcare - MeyerSession 4   American Healthcare - Meyer
Session 4 American Healthcare - Meyer
 

Ähnlich wie Online Session Accountability

Ethics presentation may 26 2011
Ethics presentation may 26 2011Ethics presentation may 26 2011
Ethics presentation may 26 2011
taj7900
 
Presentation on theme: "GCP (GOOD CLINICAL PRACTISE)"
Presentation on theme: "GCP (GOOD CLINICAL PRACTISE)"Presentation on theme: "GCP (GOOD CLINICAL PRACTISE)"
Presentation on theme: "GCP (GOOD CLINICAL PRACTISE)"
Nevin Francis
 
Chapter 4 class version(1)
Chapter 4 class version(1)Chapter 4 class version(1)
Chapter 4 class version(1)
jbnx
 
Ethics In Research
Ethics In ResearchEthics In Research
Ethics In Research
Grant Heller
 
Unit 8. Ethical Considerations in Reseaerch.pptx
Unit 8. Ethical Considerations in Reseaerch.pptxUnit 8. Ethical Considerations in Reseaerch.pptx
Unit 8. Ethical Considerations in Reseaerch.pptx
shakirRahman10
 

Ähnlich wie Online Session Accountability (20)

IRB Approval Process 2016
IRB Approval Process 2016IRB Approval Process 2016
IRB Approval Process 2016
 
Ethics presentation may 26 2011
Ethics presentation may 26 2011Ethics presentation may 26 2011
Ethics presentation may 26 2011
 
هديل القفيدي
هديل القفيديهديل القفيدي
هديل القفيدي
 
EMPHNET-PHE Course: Module seven ethical issues in public health research& in...
EMPHNET-PHE Course: Module seven ethical issues in public health research& in...EMPHNET-PHE Course: Module seven ethical issues in public health research& in...
EMPHNET-PHE Course: Module seven ethical issues in public health research& in...
 
SCHS Topic7 research ethics
SCHS Topic7 research ethicsSCHS Topic7 research ethics
SCHS Topic7 research ethics
 
Research ethics-WMB-July312022.pdf
Research ethics-WMB-July312022.pdfResearch ethics-WMB-July312022.pdf
Research ethics-WMB-July312022.pdf
 
Ethics revised 2013
Ethics revised 2013Ethics revised 2013
Ethics revised 2013
 
Regulatory framework for new drug development
Regulatory framework for new drug developmentRegulatory framework for new drug development
Regulatory framework for new drug development
 
C wchildassent
C wchildassentC wchildassent
C wchildassent
 
Medical Ethics With Research
Medical Ethics With ResearchMedical Ethics With Research
Medical Ethics With Research
 
Presentation on theme: "GCP (GOOD CLINICAL PRACTISE)"
Presentation on theme: "GCP (GOOD CLINICAL PRACTISE)"Presentation on theme: "GCP (GOOD CLINICAL PRACTISE)"
Presentation on theme: "GCP (GOOD CLINICAL PRACTISE)"
 
Clinical Trials
Clinical TrialsClinical Trials
Clinical Trials
 
institutional ethics committee
institutional ethics committeeinstitutional ethics committee
institutional ethics committee
 
Chapter 4 class version(1)
Chapter 4 class version(1)Chapter 4 class version(1)
Chapter 4 class version(1)
 
NRES Ethics In Research.pptx
NRES Ethics In Research.pptxNRES Ethics In Research.pptx
NRES Ethics In Research.pptx
 
Ethics In Research
Ethics In ResearchEthics In Research
Ethics In Research
 
Unit 8. Ethical Considerations in Reseaerch.pptx
Unit 8. Ethical Considerations in Reseaerch.pptxUnit 8. Ethical Considerations in Reseaerch.pptx
Unit 8. Ethical Considerations in Reseaerch.pptx
 
David Resnik - MedicReS World Congress 2012
David Resnik - MedicReS World Congress 2012David Resnik - MedicReS World Congress 2012
David Resnik - MedicReS World Congress 2012
 
Research Ethics and Ethics for Health Informaticians (October 31, 2017)
Research Ethics and Ethics for Health Informaticians (October 31, 2017)Research Ethics and Ethics for Health Informaticians (October 31, 2017)
Research Ethics and Ethics for Health Informaticians (October 31, 2017)
 
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptx
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptxROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptx
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptx
 

Mehr von MedXellence

Berwick the triple aim - care, health, and cost
Berwick   the triple aim - care, health, and costBerwick   the triple aim - care, health, and cost
Berwick the triple aim - care, health, and cost
MedXellence
 
Session 12 - Introduction to Information Tools
Session 12 -  Introduction to Information ToolsSession 12 -  Introduction to Information Tools
Session 12 - Introduction to Information Tools
MedXellence
 
Session 11B - Increasing MTF Effectiveness & Efficiency
Session 11B - Increasing MTF Effectiveness & EfficiencySession 11B - Increasing MTF Effectiveness & Efficiency
Session 11B - Increasing MTF Effectiveness & Efficiency
MedXellence
 
Session 11A - Increasing MTF Effectiveness & Efficiency
Session 11A -  Increasing MTF Effectiveness & EfficiencySession 11A -  Increasing MTF Effectiveness & Efficiency
Session 11A - Increasing MTF Effectiveness & Efficiency
MedXellence
 
Session 8 - Introduction to Lean Six Sigma
Session 8 - Introduction to Lean Six SigmaSession 8 - Introduction to Lean Six Sigma
Session 8 - Introduction to Lean Six Sigma
MedXellence
 
Session 7 - Patient Centered Care
Session 7 - Patient Centered CareSession 7 - Patient Centered Care
Session 7 - Patient Centered Care
MedXellence
 
Session 6D - MHS Vision
Session 6D - MHS VisionSession 6D - MHS Vision
Session 6D - MHS Vision
MedXellence
 
Session 6C - MHS Vision
Session 6C - MHS VisionSession 6C - MHS Vision
Session 6C - MHS Vision
MedXellence
 
Session 6B - MHS Vision
Session 6B -  MHS VisionSession 6B -  MHS Vision
Session 6B - MHS Vision
MedXellence
 
Session 6A - MHS Vision
Session 6A -  MHS VisionSession 6A -  MHS Vision
Session 6A - MHS Vision
MedXellence
 
Session 5 - Resource Management
Session 5 - Resource ManagementSession 5 - Resource Management
Session 5 - Resource Management
MedXellence
 
Session 4 - American Healthcare
Session 4 - American HealthcareSession 4 - American Healthcare
Session 4 - American Healthcare
MedXellence
 
Session 12 - Introduction to Information Tools
Session 12 - Introduction to Information ToolsSession 12 - Introduction to Information Tools
Session 12 - Introduction to Information Tools
MedXellence
 
April2012 Course Schedule
April2012 Course Schedule  April2012 Course Schedule
April2012 Course Schedule
MedXellence
 

Mehr von MedXellence (20)

Berwick the triple aim - care, health, and cost
Berwick   the triple aim - care, health, and costBerwick   the triple aim - care, health, and cost
Berwick the triple aim - care, health, and cost
 
Session 12 - Introduction to Information Tools
Session 12 -  Introduction to Information ToolsSession 12 -  Introduction to Information Tools
Session 12 - Introduction to Information Tools
 
Session 11B - Increasing MTF Effectiveness & Efficiency
Session 11B - Increasing MTF Effectiveness & EfficiencySession 11B - Increasing MTF Effectiveness & Efficiency
Session 11B - Increasing MTF Effectiveness & Efficiency
 
Session 11A - Increasing MTF Effectiveness & Efficiency
Session 11A -  Increasing MTF Effectiveness & EfficiencySession 11A -  Increasing MTF Effectiveness & Efficiency
Session 11A - Increasing MTF Effectiveness & Efficiency
 
Session 8 - Introduction to Lean Six Sigma
Session 8 - Introduction to Lean Six SigmaSession 8 - Introduction to Lean Six Sigma
Session 8 - Introduction to Lean Six Sigma
 
Session 7 - Patient Centered Care
Session 7 - Patient Centered CareSession 7 - Patient Centered Care
Session 7 - Patient Centered Care
 
Session 6D - MHS Vision
Session 6D - MHS VisionSession 6D - MHS Vision
Session 6D - MHS Vision
 
Session 6C - MHS Vision
Session 6C - MHS VisionSession 6C - MHS Vision
Session 6C - MHS Vision
 
Session 6B - MHS Vision
Session 6B -  MHS VisionSession 6B -  MHS Vision
Session 6B - MHS Vision
 
Session 6A - MHS Vision
Session 6A -  MHS VisionSession 6A -  MHS Vision
Session 6A - MHS Vision
 
Session 5 - Resource Management
Session 5 - Resource ManagementSession 5 - Resource Management
Session 5 - Resource Management
 
Session 4 - American Healthcare
Session 4 - American HealthcareSession 4 - American Healthcare
Session 4 - American Healthcare
 
Session 12 - Introduction to Information Tools
Session 12 - Introduction to Information ToolsSession 12 - Introduction to Information Tools
Session 12 - Introduction to Information Tools
 
Online Session - Medical Executive Data
Online Session - Medical Executive DataOnline Session - Medical Executive Data
Online Session - Medical Executive Data
 
Session 1 Casestudy Introduction
Session 1   Casestudy IntroductionSession 1   Casestudy Introduction
Session 1 Casestudy Introduction
 
April2012 Course Schedule
April2012 Course Schedule  April2012 Course Schedule
April2012 Course Schedule
 
Session 3 - Healthcare Policy Content - Diehl
Session 3 - Healthcare Policy Content - DiehlSession 3 - Healthcare Policy Content - Diehl
Session 3 - Healthcare Policy Content - Diehl
 
Session 1 - Case Study Content - Crawford
Session 1 - Case Study Content - CrawfordSession 1 - Case Study Content - Crawford
Session 1 - Case Study Content - Crawford
 
FACULTY BIOS
FACULTY BIOSFACULTY BIOS
FACULTY BIOS
 
Synopsis
SynopsisSynopsis
Synopsis
 

Kürzlich hochgeladen

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
KarakKing
 

Kürzlich hochgeladen (20)

Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Plant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptxPlant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptx
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 

Online Session Accountability

  • 1. Accountability – Executive Management of Clinical Investigation Programs Mr. John E. Baker General Counsel Uniformed Services University of the Health Sciences jbaker@usuhs.mil Ms. Carol Cooper Associate General Counsel TRICARE Management Activity carol.cooper@tma.osd.mil
  • 2. Clinical Investigation • What are we talking about? • Research – Systematic investigation designed to develop or contribute to generalizable knowledge – 32 C.F.R. 219.102(d) • Why? • “Cutting Edge” Care, Training, Mission • Who’s accountable? • Individual researchers and health care providers, IRBs, facility commanders/staffs, the services, DoD • What are we accountable for? • Adherence to all applicable laws and statutes, ethical decision-making and judgment
  • 3. Objectives • Identify the regulations regarding the conduct of clinical investigations research in medical activities • Demonstrate the function, role, and responsibilities of an Institutional Review Board (IRB) • Understand the issues regarding informed consent in clinical research • Understand the future challenges in clinical research
  • 4. Objective 1 • Identify the regulations regarding the conduct of clinical investigations research in medical activities
  • 5. Basic Principles • Belmont Report • Respect for persons • Beneficence • Justice • The Technical Stuff Matters Too • “t”s and “i”s
  • 6. Office for Human Research Protections (OHRP) • Public Health Service Act 1974 • Common Rule – 45 C.F.R. Part 46 • 16 Federal Agencies + HHS • Ethical Principles • Prospective Review by IRBs
  • 7. References • CFRs: • 45 CFR 46.101 (definitions and explanations of IRBs, assurances, informed consent) • 32 CFR 219.101-124 • DoD: • DODDIR 3216.2 (Protection of Human Subjects)
  • 8. References • Army: • AR 40-38 (clinical investigation program) • AR 70-25 (use of volunteers as research subjects)
  • 9. References • Navy: • SECNAVINST 3900.39C (Protection of Human Subjects) • BUMEDINST 6000.12A (Clinical Investigation Program) • BUMEDINST 3900.6B (Protection of Human Subjects)
  • 10. References • Air Force: • AFPD 40-4 (Clinical Investigation and Human Use in Medical Research) • AFI 40-402 (Protection of Human Subjects in Biomedical and Behavioral Research)
  • 11. Objective 2 • Demonstrate the function, role, and responsibilities of an Institutional Review Board (IRB)
  • 12. Protocol Approval Process • Assurances • Protocols • Scientific Review • Human Use
  • 13. Institutional Review Boards (IRB) • Duties: Approve, Disapprove, Modify • Monitor, Continuing Review • Suspend, Terminate • For each Protocol: • Risk/Benefit Analysis • Plan to minimize Risks • Informed Consent • Privacy/Confidentiality
  • 14. Institutional Review Boards (IRB) • Composition: • Minimum 5 Members • Both Genders • Scientific/Nonscientific • Nonaffiliated with Institution • Diversity in Experience and Expertise • Sensitive to Community • Knowledgeable of Applicable Regulations
  • 15. IRB Issues • Research Subject Selection/Recruitment • Compensation of Subjects • 24 U.S.C. § 30 • Minimizing Risks • Medical Monitor • Military Unique Environments • Conflicts of Interest
  • 16. IRB Issues • Overseas • Special Subjects • Children (Assent) • Prisoners • “Emergency” Research
  • 17. IRB Process • Greater than Minimal Risk • Expedited Review • Exempt Research (32 C.F.R. 219.101) • Educational Practices, Tests & Surveys • Existing Data • Elected Officials • Public Benefit Service Programs • Consumer Acceptance • Continuing Review
  • 18. Objective 3 • Understand the issues regarding informed consent in clinical research
  • 19. Informed Consent • Research Acknowledgement • Alternatives • Purpose of Study • Compensation • Describe Procedures • Medical Care for Injuries • Duration • Experimental • Voluntary Nature • Potential Risks – Withdrawal • Potential Benefits • POC for Questions
  • 20. Objective 4 • Understand the future challenges in clinical research
  • 21. Command Issues • Outside Sponsorship • Technology Transfer • CRADAs • “Sensitive” Research • Cooperative Research • Joint IRBs • Publication
  • 22. On The Horizon • Recommendations for Reform: • Recast IRB Requirements • Strengthen Continuing Protections • Enact Educational Requirements • Insulate IRBs from Conflicts • Recognize Workload Pressures • Reengineer Federal Oversight Process
  • 23. Individual Accountability • Researcher Charged With Negligent Homicide (Criminal Liability) • IRB Chair Named in Million $$ Lawsuit (Civil Liability) • Commander Relieved (Malfeasance, Nonfeasance, Administrative Action) • 15-6 Investigation for Research Misconduct Clears Lab Personnel
  • 24. Institutional Liability • U.S. Halts Research on Humans at Duke University • Johns Hopkins: Healthy Volunteer in Asthma Trial Dies After Inhaling Drug • DOD Grounds Medical Research Program at ________________
  • 25. The Bottom Line • Leadership • Visibility • Good People • Support
  • 26. Questions/Answers • Your Team (Research Director, IRB Chair, IRB Administrator, Legal Advisor) • Technical Chain (DCS-Research/SG Legal Advisor) • http://www.bioethics.gov • jbaker@usuhs.mil • carol.cooper@tma.osd.mil

Hinweis der Redaktion

  1. Critical Decision Making for Medical Executives: Keys to Improving Healthcare Delivery